primary mediastinal large b-cell lymphoma Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (1)

Phase 1 (1)

Interventional (1)

Memorial Sloan Kettering Cancer Center (1)

No (1)

No (1)

Adult (18+) (1)

I am/have/had

I am/have/hadrecurrent disease

I am/have/hadburkitt's lymphoma

I am/have/hadrichter syndrome

I am/have/hadchemoimmunotherapy

I am/have/hadlarge cell lymphoma

I am/have/hadstem cell transplantation

I am/have/hadlymphoma

I am/have/hadfollicular lymphoma

I am/have/hadmonoclonal antibody therapy

I am/have/haddiffuse large b-cell lymphoma

I am/have/hadoxygen saturation

I am/have/hadb-cell lymphoma

I am/have/hadcancer

I am/have/hadpulse oximetry

added new label for I am/have/had

more

I am looking for

I am looking foranti-cd20 monoclonal antibody

I am looking fordirect bilirubin

I am looking formonoclonal antibodies

I am looking fortositumomab

I am looking foranthracyclines

I am looking forbiological factors

I am looking foranthracycline

I am looking forvenetoclax

I am looking forconjugated bilirubin

I am looking foribrutinib

I am looking foranti-cd20 antibody

I am looking forbiologic agent

I am looking foridelalisib

I am looking forlenalidomide

I am looking formonoclonal protein

added new label for I am looking for

more

Advanced Filters

Loading...

Found 1 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Phase 1
For Seniors
For adults
Recruiting in 10s
Interventional Study
all
Family Medicine
Recruiting

19(T2)28z1xx Chimeric Antigen Receptor (CAR) T Cells in People With B-Cell Cancers

The purpose of this study is to test the safety of 19(T2)28z1xx CAR T cells in people with relapsed/refractory B-cell cancers. The researchers will try to find the highest dose of 19(T2)28z1xx CAR T cells that causes few or mild side effects in participants. Once they find this dose, they …

direct bilirubin

monoclonal antibodies

tositumomab

burkitt's lymphoma

richter syndrome

0 views
05 Aug, 2020

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2026 All rights reserved.